BusinessAXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&DBy Nasdaq OMXNov 3, 2016, 1:01 PM UTC
BusinessAXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&DBy Nasdaq OMXNov 3, 2016, 1:01 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
BusinessAXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa PharmaceuticalsBy Nasdaq OMXSep 19, 2016, 1:00 PM UTC
BusinessMedical Marijuana, Inc. Investment – AXIM Biotech – Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in InterviewBy Nasdaq OMXFeb 25, 2016, 2:00 PM UTC
BusinessAXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known CureBy Nasdaq OMXFeb 18, 2016, 2:00 PM UTC
